APA (7th ed.) Citation

Wu, Z., Zhang, Z., Zhang, D., & Li, Z. (2024). Remarkable response to third-generation EGFR-TKI plus crizotinib in a patient with pulmonary adenocarcinoma harboring EGFR and ROS1 co-mutation: A case report. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Wu, Zhiming, Zelin Zhang, Dongdong Zhang, and Zengyan Li. Remarkable Response to Third-generation EGFR-TKI Plus Crizotinib in a Patient with Pulmonary Adenocarcinoma Harboring EGFR and ROS1 Co-mutation: A Case Report. Frontiers Media S.A, 2024.

MLA (9th ed.) Citation

Wu, Zhiming, et al. Remarkable Response to Third-generation EGFR-TKI Plus Crizotinib in a Patient with Pulmonary Adenocarcinoma Harboring EGFR and ROS1 Co-mutation: A Case Report. Frontiers Media S.A, 2024.